One complaint that I continue to hear from constituent companies is that the FDA's medical device review process is unpredictable and inconsistent.
Kay Hagan: “One complaint that I continue to hear from constituent companies is that the FDA's medical device review process is…”
On the recordNovember 14, 2011
Source
congress.govEditor's note · Context
Hagan expresses concerns about the FDA's review process for medical devices.
Share
More from Kay Hagan
Dec 11, 2014
My staff knew how important it was to me that my office be as open and as accessible as possible to the people of North Carolina, and my team worked every single day to help us reach that goal. Over the last 6 years, we held a townhall in…
Sep 15, 2014
Do you see the presence of radicalized Westerners fighting with ISIS and the Khorasan as a threat to the United States?
Jul 9, 2014
it is with great pride that I rise to speak about the Bipartisan Sportsmen's Act of 2014. Before proceeding, I wish to thank Senator Murkowski for being a true partner in developing and building support for the sportsmen's package. I am…





